Argus Investors Counsel’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,820	Closed	-$1.3M	–	120
2024 Q4	$1.3M	Sell	1,820 -21	-1%	-$15K	0.87%	36
2024 Q3	$1.94M	Buy	1,841 +290	+19%	+$305K	1.26%	27
2024 Q2	$1.63M	Buy	1,551 +86	+6%	+$90.4K	1%	31
2024 Q1	$1.41M	Buy	+1,465	New	+$1.41M	0.87%	52